Nomura Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$106M Buy
300,929
+1,762
+0.6% +$628K 0.27% 67
2025
Q4
$97.9M Sell
299,167
-10,047
-3% -$3.19M 0.25% 71
2025
Q3
$87.3M Sell
309,214
-26,531
-8% -$7.69M 0.23% 82
2025
Q2
$93.7M Sell
335,745
-3,174
-0.9% -$899K 0.26% 80
2025
Q1
$106M Buy
338,919
+394
+0.1% +$116K 0.32% 65
2024
Q4
$88.2M Sell
338,525
-1,732
-0.5% -$514K 0.27% 78
2024
Q3
$110M Buy
340,257
+11,348
+3% +$3.71M 0.34% 61
2024
Q2
$103M Sell
328,909
-18,279
-5% -$5.37M 0.35% 61
2024
Q1
$98.7M Sell
347,188
-34,074
-9% -$9.97M 0.36% 61
2023
Q4
$110M Buy
381,262
+5,125
+1% +$1.4M 0.45% 44
2023
Q3
$101M Sell
376,137
-10,341
-3% -$2.58M 0.47% 40
2023
Q2
$85.8M Buy
386,478
+89,376
+30% +$20.7M 0.4% 53
2023
Q1
$71.8M Sell
297,102
-126,930
-30% -$31.2M 0.38% 52
2022
Q4
$111M Sell
424,032
-39,597
-9% -$10.6M 0.65% 31
2022
Q3
$105M Sell
463,629
-14,242
-3% -$3.45M 0.67% 24
2022
Q2
$116M Sell
477,871
-12,098
-2% -$2.96M 0.73% 18
2022
Q1
$118M Sell
489,969
-86,364
-15% -$19.8M 0.64% 23
2021
Q4
$130M Buy
576,333
+111,787
+24% +$23.6M 0.66% 23
2021
Q3
$98.8M Buy
464,546
+52,199
+13% +$12M 0.56% 31
2021
Q2
$101M Buy
412,347
+24,596
+6% +$6.05M 0.58% 25
2021
Q1
$96.5M Sell
387,751
-9,516
-2% -$2.27M 0.61% 26
2020
Q4
$91.3M Buy
397,267
+10,341
+3% +$2.38M 0.61% 31
2020
Q3
$98.3M Sell
386,926
-15,465
-4% -$3.83M 0.75% 17
2020
Q2
$94.9M Buy
402,391
+2,011
+0.5% +$459K 0.8% 18
2020
Q1
$81.2M Sell
400,380
-15,360
-4% -$3.36M 0.84% 19
2019
Q4
$100M Sell
415,740
-13,501
-3% -$2.98M 0.9% 17
2019
Q3
$83.1M Buy
429,241
+46,066
+12% +$8.84M 0.79% 23
2019
Q2
$70.6M Sell
383,175
-191,979
-33% -$34.4M 0.7% 28
2019
Q1
$109M Buy
575,154
+2,471
+0.4% +$472K 1.07% 15
2018
Q4
$111M Buy
572,683
+6,333
+1% +$1.24M 1.25% 14
2018
Q3
$117M Sell
566,350
-12,445
-2% -$2.45M 1.14% 15
2018
Q2
$107M Sell
578,795
-1,978
-0.3% -$350K 1.11% 16
2018
Q1
$99M Buy
580,773
+20,611
+4% +$3.78M 1.08% 16
2017
Q4
$97.4M Buy
560,162
+22,790
+4% +$4.03M 1.13% 17
2017
Q3
$100M Buy
537,372
+43,205
+9% +$7.66M 1.29% 10
2017
Q2
$85.1M Buy
494,167
+118,398
+32% +$19.3M 1.14% 14
2017
Q1
$61.7M Buy
375,769
+93,546
+33% +$15.5M 0.87% 20
2016
Q4
$41.3M Sell
282,223
-1,932
-0.7% -$291K 0.74% 19
2016
Q3
$47.4M Sell
284,155
-18,480
-6% -$3.13M 0.85% 18
2016
Q2
$46M Buy
302,635
+9,246
+3% +$1.44M 0.86% 18
2016
Q1
$44M Buy
293,389
+44,144
+18% +$6.56M 0.84% 17
2015
Q4
$40.5M Buy
249,245
+1,067
+0.4% +$168K 0.78% 23
2015
Q3
$34.3M Sell
248,178
-1,575
-0.6% -$248K 0.69% 29
2015
Q2
$38.3M Sell
249,753
-4,393
-2% -$704K 0.71% 31
2015
Q1
$40.6M Sell
254,146
-32,749
-11% -$5.16M 0.72% 26
2014
Q4
$46M Sell
286,895
-28,712
-9% -$4.47M 0.8% 22
2014
Q3
$44.3M Sell
315,607
-6,878
-2% -$898K 0.78% 24
2014
Q2
$38.2M Buy
322,485
+100,483
+45% +$11.6M 0.71% 27
2014
Q1
$27.4M Buy
222,002
+26,842
+14% +$3.26M 0.5% 54
2013
Q4
$22.3M Sell
195,160
-688
-0.4% -$78.3K 0.4% 63
2013
Q3
$21.9M Buy
195,848
+2,448
+1% +$265K 0.42% 61
2013
Q2
$19.1M Buy
+193,400
New +$20.1M 0.38% 56

Other funds holding AMGN

Nomura Asset Management's AMGN Position: Q1 2026 in Review

Nomura Asset Management increased its Amgen (AMGN) stake by 0.59% in Q1 2026, buying an estimated $628K and bringing the position to 300,929 shares worth $106M. The position accounts for 0.27% of the portfolio, ranked #67.

Nomura Asset Management first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $130M in Q4 2021. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Nomura Asset Management held 300,929 shares of Amgen worth $106M as of Q1 2026.
  • Nomura Asset Management bought 1,762 Amgen shares in Q1 2026, an estimated $628K.
  • Amgen made up 0.27% of Nomura Asset Management's portfolio in Q1 2026, its #67 holding.
  • Nomura Asset Management first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Nomura Asset Management's Amgen position peaked at $130M in Q4 2021.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Nomura Asset Management's 13F filing for Q1 2026, filed 11 May 2026.